Paragon Care (ASX: PGC) is an Australian-listed company in the Healthcare sector with a market capitalisation of $248.3M and the 614th-largest security on the ASX by market capitalisation. The PGC share price is $0.15, down 3.23% today and down 62.82% over the past 12 months. Shares have traded between $0.135 and $0.41 over the past 52 weeks. In its most recent reported period (ending 31 Dec 2025), Paragon Care reported revenue of $1.90B and a net loss of $21.3M.
About Paragon Care Limited
Paragon Care Limited operates as a prominent supplier of durable medical equipment, various medical devices, and consumable healthcare products, serving the health and aged care sectors across Australia, New Zealand, and internationally. The company delivers specialized clinical solutions for professionals in areas such as anaesthesiology, intensive care, cardiology, vascular surgery, and pain management. It is also involved in the development, production, and distribution of essential immunohaematology laboratory products, including reagent red blood cells and monoclonal blood grouping reagents. Furthermore, Paragon Care offers a range of eye care products, encompassing ophthalmology, optometry, neonatal vision screening, and specialized procedural kits. Its services extend to neonatal and paediatric assessment and treatment, covering newborn hearing and vision screening, jaundice management, targeted temperature regulation, cerebral function monitoring, and seizure detection, along with dedicated pain management and enteral feeding solutions. For surgical applications, the company provides products for hip and knee arthroplasty, infection prevention, pain management, biologics, and general operating room requirements. Additionally, it offers vital equipment repair and maintenance services. Paragon Care's product line includes sophisticated tools like sterilizable transducers for diverse surgical procedures such as neurology, hepatobiliary, renal, colorectal, vascular, laparoscopic, and robotic operations. The company also supplies ultrasound systems, shockwave therapy, lasers, and associated accessories crucial for infection control. For the veterinary market, it distributes a comprehensive array of items, including point-of-care diagnostics, therapeutic lasers, oncology delivery products, centrifuges, autoclaves, IV lines, fluid therapy products, wearable constant-rate infusion systems, and IT solutions. Moreover, Paragon Care addresses communication and infrastructure needs within healthcare settings, providing telephony systems, nurse call solutions, access control, CCTV, cordless communication devices, and Wi-Fi products. Established in 1994 and headquartered in Melbourne, Australia, Paragon Care Limited was initially known as Citrofresh International Limited before adopting its current name in June 2008.
